- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Relapsed and Refractory Multiple Myeloma in Finland
Total 1582 results
-
BayerNovartis Pharmaceuticals; Biogen; EPID Research; Merck Serono Europe LtdCompleted
-
BiogenCompletedRelapsing-remitting Multiple SclerosisBelgium, Denmark, Finland, Netherlands, Norway, Sweden, Switzerland, United Kingdom
-
Amsterdam UMC, location VUmcOdense University Hospital; Helsinki University Central Hospital; Aarhus University... and other collaboratorsRecruitingCML, RelapsedDenmark, Norway, Sweden, Netherlands, Finland, France, Germany
-
National Cancer Institute (NCI)Active, not recruitingSmoldering Multiple Myeloma | Light Chain Deposition DiseaseUnited States, Puerto Rico, Ireland
-
Norwegian University of Science and TechnologyCompletedChronic Myeloid LeukemiaSweden, Finland, Norway
-
European Society for Blood and Marrow TransplantationCompletedMultiple MyelomaAustria, Denmark, Germany, Finland, Canada, Sweden, Norway, France, Italy, United Kingdom, Turkey
-
Amsterdam UMC, location VUmcMerck Sharp & Dohme LLC; Novartis; Uppsala University HospitalTerminatedChronic Myeloid LeukemiaNetherlands, Denmark, Sweden, Finland, Norway
-
PfizerBristol-Myers SquibbRecruiting
-
OncotherapeuticsAmgenTerminatedMultiple MyelomaUnited States
-
Brown UniversityPfizer; The Miriam Hospital; Rhode Island HospitalActive, not recruitingAcute Myeloid LeukemiaUnited States
-
Syndax PharmaceuticalsAvailable
-
Finnish MS SocietySeinajoki Central Hospital; Social Insurance Institution, Finland; Tampere University...Completed
-
OncotherapeuticsTakedaCompletedMultiple MyelomaUnited States
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
CelgeneCompletedMultiple MyelomaUnited States, Canada, Germany, Spain, Denmark, Netherlands, Finland, Italy
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisBelgium, Bulgaria, Canada, Croatia, Czech Republic, Finland, Germany, Hungary, Italy, Lithuania, Poland, Russian Federation, Serbia, Spain, Turkey, Ukraine, United Kingdom
-
National Cancer Institute (NCI)Recruiting
-
Kati JärveläCompletedPostoperative Pain | Opioid Related DisordersFinland
-
Kuopio University HospitalWithdrawn
-
Kuopio University HospitalUniversity of Eastern FinlandCompleted
-
European Organisation for Research and Treatment...CompletedLymphoma | Unspecified Childhood Solid Tumor, Protocol Specific | Myelodysplastic Syndromes | Leukemia | Unspecified Adult Solid Tumor, Protocol Specific | Infection | Multiple Myeloma and Plasma Cell Neoplasm | Fever, Sweats, and Hot Flashes | Bone Marrow SuppressionSwitzerland, United States, Canada, United Kingdom, Belgium, Israel, Slovakia, Finland, Germany, France, Turkey, Czech Republic, Greece
-
Norwegian University of Science and TechnologyCompletedLeukemia, Myeloid, Chronic-PhaseSweden, Finland, Norway
-
Finnish Foundation for Alcohol StudiesCompleted
-
Finnish Institute for Health and WelfareCompletedAlcohol DependenceFinland
-
PfizerRecruitingMultiple MyelomaUnited States, Japan, Spain, Canada, Finland, Argentina, Norway
-
PfizerActive, not recruitingLymphoma | Diffuse Large B-Cell Lymphoma | Acute Myeloid Leukemia | Multiple MyelomaUnited States
-
Eli Lilly and CompanyBioMS Technology Corp.CompletedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Germany, Latvia, Netherlands, Spain, Sweden, United Kingdom
-
Janssen-Cilag International NVCompletedMultiple MyelomaFrance, Poland, Belgium, Germany, Israel, Portugal, Turkey, Finland, Sweden, Netherlands, Norway
-
Kuopio University HospitalRecruitingAlcohol Dependence | Alcoholism | Alcohol-Related Disorders | Substance Use Disorders | Substance Abuse | Adolescent Behavior | Adolescent Problem BehaviorFinland
-
Tampere University HospitalTampere UniversityEnrolling by invitation
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedPain | Urinary Complications | Breast Adenocarcinoma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | Metastatic Malignant Neoplasm to the Bone | Musculoskeletal ComplicationUnited States, Puerto Rico
-
PfizerAvailableMultiple MyelomaUnited States, Canada
-
Aronex PharmaceuticalsCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Infection | Multiple Myeloma and Plasma Cell NeoplasmUnited States
-
Eli Lilly and CompanyBioMS Technology Corp.TerminatedSecondary Progressive Multiple SclerosisCanada, Estonia, Denmark, Finland, Latvia, Spain, Sweden, United Kingdom, Germany, Netherlands
-
Novartis PharmaceuticalsActive, not recruitingAcute Myeloid Leukemia (AML) | High-risk Myelodysplastic Syndrome (MDS)Spain, Singapore, Australia, Germany, Italy, Finland, United States
-
Tampere UniversityCompleted
-
BayerCompletedMultiple SclerosisGermany, Austria, United Kingdom, Israel, Belgium, Finland
-
Mitsubishi Tanabe Pharma CorporationCompletedRelapsing-remitting Multiple SclerosisCroatia, Bulgaria, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Lithuania, Poland, Belgium, Hungary, Serbia, Finland, Ukraine, Switzerland, Canada, Turkey
-
Tampere UniversityTampere University Hospital; Sitra, the Finnish Innovation FundCompletedHypertension | Diabetes | Dyslipidemias | Overweight and ObesityFinland
-
Sociedad Espanola del DolorRecruiting
-
Helsinki University Central HospitalGöteborg UniversityCompleted
-
Faron Pharmaceuticals LtdTerminatedPreventive Medicine | Multi Organ FailureLithuania, Estonia, Finland
-
University of HelsinkiCompleted
-
University of HelsinkiCompleted
-
Tarix PharmaceuticalsConstant Therapeutics LLCTerminatedLymphoma, Non-Hodgkin | Multiple Myeloma | Hodgkin DiseaseUnited States
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
CelgeneActive, not recruitingMultiple MyelomaUnited States, Canada, Denmark, Australia, Belgium, Finland, Greece, Japan, Korea, Republic of, Spain, United Kingdom
-
Turku University HospitalUniversity of Turku; Academy of Finland; Foundation for Paediatric Research,... and other collaboratorsCompletedSubstance-Related Disorders | Depression | Anxiety | Pregnancy, High Risk | Parenting | Maternal-Fetal Relations | Prenatal Care | Fetal Exposure During Pregnancy | Perinatal OutcomeFinland
-
Tampere University HospitalDeaconess Foundation; A-Clinic FoundationRecruitingSoft Tissue Injuries | Substance Dependence | Foreign Bodies | Drug Abuse, Intravenous | Needle InjuryFinland
-
Helsinki University Central HospitalTerminatedPain, Postoperative | Medication Adherence | Adverse Drug EventFinland